Regulatory alerts roundup

CBD-Intel regulatory news in brief, 25th February-2nd March

Written by CBD-Intel || 2nd March 2020 || Regulatory alerts roundup | Regulation and Legislation | Geographies: Europe

This week's regulatory news in brief brings updates from the EU, Mexico, the US, Lebanon, Malawi, Peru and the Philippines ...

Restricted content. Do you want to read more?

Subscribers: Login here

Featured topic

The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.

Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.

Blog | Policy and politics | US federal regulation